Intra-Cellular Therapies, Inc. is a biopharmaceutical company founded on Nobel prize-winning research that allows it to understand how therapies affect the inner-workings of cells in the body. The Company leverages this intracellular approach to deliver innovative treatments for people living with complex psychiatric and neurologic diseases.
WORK WITH US
Patient needs are at the core of our efforts at Intra-Cellular Therapies and we are always looking for talented individuals who share our values to join our team. Please explore open positions by clicking the “Jobs” tab above.
|
|
|
501-1,000 employees
View all Intra-Cellular Therapies employees
|
|
Pharmaceuticals
|
|
430 East 29th Street, Suite 955, New York, New York 10016, US
|
|
2002
|
|
Research And Development, Biopharmaceuticals, Bipolar Disorder, Parkinson's Disease, Parkinson's Disease, Drug Product Development, Schizophrenia, Major Depressive Disorder, Drug Product Development, Biopharmaceuticals, Central Nervous System (Cns) Disorders, Neuropsychiatric And Neurodegenerative Diseases, Bipolar Disorder, Schizophrenia, Major Depressive Disorder, Central Nervous System (Cns) Disorders, Research And Development
|
Sharon Mates is the CEO of Intra-Cellular Therapies. To contact Sharon Mates email at [email protected].
The decision makers in Intra-Cellular Therapies are Antonia Periclou, Daniel C Utzinger, Debra Marchese, etc. Click to Find Intra-Cellular Therapies decision makers emails.
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.